Hoffmann-La Roche: Asthma trials
The registry lists 41 Asthma studies with Hoffmann-La Roche as lead sponsor. 0 are open to participants now and 16 have results posted.
Phase 1 3Phase 2 19Phase 3 9Phase 4 7No phase 3(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic CoughCompletedNCT05660850Phase 2Results posted
- A Study to Assess the Impact of Omalizumab on Exercise Capacity, Physical Activity, and Sleep Quality in Participants With Moderate to Severe Allergic AsthmaTerminatedNCT04195958Phase 4Results posted
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MTPS9579A in Patients With Asthma Requiring Inhaled Corticosteroids and a Second ControllerCompletedNCT04092582Phase 2Results posted
- A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Uncontrolled Severe AsthmaCompletedNCT02918019Phase 2Results posted
- A Study Evaluating the Efficacy and Safety of Lebrikizumab in Adult Patients With Mild to Moderate AsthmaCompletedNCT02104674Phase 3Results posted
- A Study of Lebrikizumab (RO5490255) in Participants With Severe Oral Corticosteroids (OCS) Dependent AsthmaTerminatedNCT01987492Phase 2Results posted
- A Study in Participants With Asthma Initiating Treatment With Omalizumab (Xolair)CompletedNCT01922037Phase 4Results posted
- A Study of Lebrikizumab in Adolescent Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller MedicationTerminatedNCT01875003Phase 3Results posted
- A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller MedicationCompletedNCT01867125Phase 3Results posted
- A Study Evaluating the Persistency of Response With or Without Xolair (Omalizumab) After Long-term TherapyCompletedNCT01125748Phase 4Results posted
- Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair DosingCompletedNCT00813748Results posted
- The Safety and Utility of Skin Testing With XOLAIR® (Omalizumab) and Placebo Omalizumab (Formulation Excipients)CompletedNCT00777764Phase 4Results posted
- A Study of Omalizumab in Preventing Bronchoconstriction Following Environmental Cat Dander Exposure in Patients With Cat Dander-induced AsthmaCompletedNCT00495612Phase 4Results posted
- A Study of Omalizumab in the Prevention of Allergen Induced Airway Obstruction in Adults With Mild Allergic AsthmaCompletedNCT00434434Phase 2Results posted
- A Study of Omalizumab (Xolair) in Subjects With Moderate to Severe Persistent Asthma (EXTRA)CompletedNCT00314574Phase 3Results posted
- A Prospective, Randomized, Double-Blind Study of the Efficacy of Omalizumab (Xolair) in Atopic Asthmatics With Good Lung Capacity Who Remain Difficult to Treat (EXACT)CompletedNCT00096954Phase 4Results posted
- A Study to Investigate the Safety, Pharmacokinetics, and Immunogenicity of BITS7201A in Healthy Volunteers and Participants With Mild Atopic AsthmaCompletedNCT02748642Phase 1
- A Single-Arm Study to Evaluate Administration of Lebrikizumab by Participants or Caregivers in the Home SettingWithdrawnNCT02546869Phase 3
- Longitudinal Cohort Study in Participants With Severe Asthma to Assess BiomarkersCompletedNCT02537691Phase 4
- A Study Evaluating the Effects of Lebrikizumab on Airway Eosinophilic Inflammation in Participants With Uncontrolled AsthmaCompletedNCT02099656Phase 2
- A Study to Measure Serum Periostin, Asthma-Related Biomarkers and Response to Prednisolone in Adult and Adolescent Patients With Severe Oral Corticosteroid-Dependent AsthmaCompletedNCT01948401Phase 2
- A Study of Lebrikizumab in Participants With Uncontrolled Asthma on Inhaled Corticosteroids and a Second Controller MedicationCompletedNCT01868061Phase 3
- A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)CompletedNCT01582503Phase 2
- A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)CompletedNCT01545453Phase 2
- A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)CompletedNCT01545440Phase 2
- A Study of MEMP1972A in the Prevention of Allergen-Induced Airway Obstruction in Patients With Mild Asthma (SOLARIO)CompletedNCT01196039Phase 2
- A Study of RO4989991 in Patients With Allergic RhinitisCompletedNCT01152619Phase 1
- A Study of huMAb OX40L in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic AsthmaCompletedNCT00983658Phase 2
- A Study to Evaluate Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Not Taking Inhaled CorticosteroidsCompletedNCT00971035Phase 2
- A Study of RO5036505 in Patients With Moderate to Severe AsthmaWithdrawnNCT00967590Phase 2
- A Study of Lebrikizumab (MILR1444A) in Adult Patients With Asthma Who Are Inadequately Controlled on Inhaled CorticosteroidsCompletedNCT00930163Phase 2
- A Study to Evaluate MILR1444A in the Prevention of Allergen-Induced Airway Obstruction in Adults With Mild Allergic AsthmaCompletedNCT00781443Phase 2
- A Single Ascending Dose Study of R1671 in Patients With Mild Intermittent Asymptomatic Asthma.CompletedNCT00517816Phase 1
- A Study to Evaluate the Safety and Efficacy of HAE1 in Subjects With Moderate to Severe Allergic AsthmaCompletedNCT00406965Phase 2
- A Study to Evaluate the Safety of Xolair in Moderate to Severe Persistent Asthma Patients (ALTO)CompletedNCT00401596Phase 3
- An Observational Study of the Use and Safety of Xolair® During PregnancyCompletedNCT00373061
- A Study of Xolair to Evaluate Effectiveness and Long-Term Safety in Patients With Moderate to Severe AsthmaCompletedNCT00252135
- A Continued Access Protocol to Provide Xolair to Patients With Severe Allergic AsthmaCompletedNCT00109200Phase 3
- An Extension Study of Xolair in Moderate to Severe, Persistent Asthma Patients Who Completed Study Q2143gCompletedNCT00109187Phase 3
- Inhaled Corticosteroid Replacement Study - Efficacy and Safety of Ro 27-2441 (Test Drug) in Moderate Persistent AsthmaCompletedNCT00048022Phase 2
- Evaluation of Various Doses of Ro 27-2771 (Test Drug) in Asthmatic Patients Not Treated With Inhaled CorticosteroidsCompletedNCT00048009Phase 2